Arthritides in the elderly;Le artropatie infiammatorie nell'età senile

Recenti Progressi in Medicina

Volumn 95, Issue 9, 2004, Pages 432-442+456

  Pipitone, Nicolò ^a,b   Pitzalis, Costantino ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

Arthritis; Elderly; Polymyalgia rheumatica

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYTOKINE; INTERLEUKIN 6; METHOTREXATE; PRASTERONE;

AGED; ARTHRITIS; ARTHROPATHY; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; EDEMA; ELDERLY CARE; HUMAN; KIDNEY FUNCTION; METABOLISM; REVIEW; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SENILITY; SERODIAGNOSIS; SYNOVITIS;

ADRENAL CORTEX HORMONES; ADULT; AGE FACTORS; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS; ARTHRITIS, RHEUMATOID; DIAGNOSIS, DIFFERENTIAL; EDEMA; HUMANS; MIDDLE AGED; POLYMYALGIA RHEUMATICA; PROGNOSIS; SYNOVITIS; TIME FACTORS;

EID: 3543040053     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. WHO. http://www.who.int/hpr/ageing/index.htm. 2001.
2. Morgan J, Furst DE. Implications of drug therapy in the elderly. Clin Rheum Dis 1986; 12: 227-44.
3. Sack, K. E. L'uso dei FANS in età avanzata. Geriatrics 1990; 7: 56-66.
4. Menkes, C. J. Renal and hepatic effects of NSAIDs in the elderly. Scandinavian Journal of Rheumatology 1989; suppl. 83: 11-13.
5. Schaeverbeke T, Vernhes JP, Bannwarth B, Dehais J. Is remitting seronegative symmetrical synovitis with pitting oedema (RS3PE syndrome) associated with HLA-A2? [letter]. British Journal of Rheumatology 1995; 34: 889-90.
6. Straub RH, Konecna L, Hrach S, Rothe G, Kreutz M, Scholmerich J, Falk W, Lang B. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 1998; 83: 2012-17.
7. Kamilaris TC, DeBold CR, Pavlou SN, Island DP, Hoursanidis A, Orth DN. Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function. J Clin Endocrinol Metab 1997; 65: 994-9.
8. Espinoza LR, Jara LJ, Silveira LH, Martinez-Osuna P, Zwolinska JB, Kneer, C, Aguilar JL. Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications. American Journal of Medicine 1991; 90: 474-8.
9. Chiovato L, Mariotti S, Pinchera A. Thyroid diseases in the elderly. Baillières Clinical Endocrinology & Metabolism 1997; 11: 251-70.
10. Bagchi N, Brown TR, Parish RF. Thyroid dysfunction in adults over age 55 years. A study in an urban US community. Archives of Internal Medicine 1990; 150: 785-7.
11. Bland JH, Frymoyer JW. Rheumatic syndromes of myxedema. New England Journal of Medicine 1970; 282: 1171-4.
12. Hobbs MV, Ernst DN. T cell differentiation and cytokine expression in late life. Dev Comp Immunol 1997; 21: 461-70.
13. Fabris N, Mocchegiani E, Amadio L, Zannotti M, Licastro F, Franceschi C. Thymic hormone deficiency in normal ageing and Down's syndrome: is there a primary failure of the thymus? Lancet 1984; i: 983-6.
14. Pozzilli P, Visalli N, Cavallo MG, Beales P, Negri M, Ghirlanda G, Papa V, Andreani D. Normalization of the CD4/CD8 lymphocyte ratio and increased B lymphocytes in long standing diabetic patients following therapy with thymopentin. Diabetes Res 1987; 6: 51-6.
15. Pawelec G, Adibzadeh M, Rehbein A, Hahnel K, Wagner W, Engel A. In vitro senescence models for human T lymphocytes. Vaccine 2000; 18: 1666-74.
16. Solana R, Mariani E. NK and NK/T cells in human senescence. Vaccine 2000; 18: 1613-20.
17. Polignano A, Tortorella C, Venezia A, Jirillo E, Antonaci S. Age-associated changes of neutrophil responsiveness in a human healthy elderly population. Cytobios 1994; 80: 145-53.
18. Tortorella C, Ottolenghi A, Pugliese P, Jirillo E, Antonaci S. Relationship between respiratory burst and adhesiveness capacity in elderly polymorphonuclear cells. Mechanisms of Ageing & Development 1993; 69: 53-63.
19. Diaz-Jauanen E, Strickland RG, Williams RC. Studies of human lymphocytes in the newborn and the aged. American Journal of Medicine 1975; 58: 620-8.
20. Symmons DP, Barrett EM, Bankhead CR, Scott DG, Silman AJ. The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol 1994; 33: 735-9.
21. van Schaardenburg D, Breedveld FC. Elderly-onset rheumatoid arthritis. Seminars in Arthritis & Rheumatism 1994; 23: 367-78.
22. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
23. R.S.Cecil, W.H.Krammerer. Arthritis in the aged. American Journal of Medicine 1951; 13: 439-45.
24. Deal CL, Meenan RF, Goldenberg DL, Anderson JJ, Sack B, Pastan RS, Cohen AS. The clinical features of elderly-onset rheumatoid arthritis. A comparison with younger-onset disease of similar duration. Arthritis & Rheumatism 1985; 28: 987-94.
25. Terkeltaub R, Esdaile J, Decary F, Tannenbaum H. A clinical study of older age rheumatoid arthritis with comparison to a younger onset group. Journal of Rheumatology 1983; 10: 418-24.
26. Moesmann G. Clinical features in subacute rheumatoid arthritis in old age. Acta Rheumatologica Scandinavica 1968; 14: 285-97.
27. Bajocchi G, La Corte R, Locaputo A, Govoni M, Trotta F. Elderly onset rheumatoid arthritis: clinical aspects. Clinical & Experimental Rheumatology 2000; 18: S49-50.
28. Caroit M. Polyarthritis in the elderly. Zeitschrift für Gerontologie 1993; 26: 13-6.
29. Kaltenhauser S, Wagner U, Schuster E, Wassmuth R, Arnold S, Seidel W, Troltzsch M, Loeffler M, Hantzschel H. Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity. Journal of Rheumatology 2001; 28: 735-44.
30. van Zeben D, Hazes JM, Zwinderman AH, Cats A, Schreuder GM, D'Amaro J, Breedveld FC. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a follow-up study. Arthritis & Rheumatism 1991; 34: 822-30.
31. Meretey K, Gomor B, Gorgenyi F, Gyody E, Petranyi GG. Study of autoantibodies, natural antibodies and IgE level in four families with rheumatoid arthritis. Zeitschrift für Rheumatologie 1987; 46: 189-95.
32. Healey LA. Rheumatoid arthritis in the elderly. Clinics in Rheumatic Diseases 1986; 12: 173-9.
33. Terkeltaub R, Decary F, Esdaile J. An immunogenetic study of older age onset rheumatoid arthritis. Journal of Rheumatology 1984; 11: 147-9.
34. Ferraccioli G, Savi M. Association between DR antigens, rheumatoid arthritis with and without extraarticular features and systemic lupus erythematosus in Northern Italy. Journal of Rheumatology 1988; 15: 51-3.
35. Salvarani C, Macchioni P, Mantovani W, Portioli I. Polymyalgia rheumatica and seronegative rheumatoid arthritis: some considerations based on a northern Italian population. Journal of Rheumatology 1993; 20: 756-7.
36. Straub RH, Miller LE, Schölmerich J, Zietz B. Cytokines and hormones as possible links between endocrino-senescence and immuno-senescence. Journal of Neuroimmunology 2000; 109: 10-5.
37. Pitzalis C, Pipitone N, Pipitone V, Fioravanti A, Marcolongo R. L'artrite reumatoide: recenti acquisizioni e nuovi concetti patogenetici. Recenti Progressi in Medicina 2001; 92: 217-22.
38. Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi, GS. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis & Rheumatism 1992; 35: 1281-8.
39. Jefferies WM. The etiology of rheumatoid arthritis. Medical Hypotheses 1998; 51: 111-4.
40. Jefferies WM. Mild adrenocortical deficiency, chronic allergies, autoimmune disorders and the chronic fatigue syndrome: a continuation of the cortisone story. Medical Hypotheses 1994; 42: 183-9.
41. Merlino LA, Cerhan JR, Criswell LA, et al. Female reproductive factors and the risk of elderly onset rheumatoid arthritis. ACR 64th Meeting Poster [110]. 2000.
42. Perazella MA. COX-2 inhibitors and the kidney. Hosp Pract (Off Ed) 2001; 36: 43-6.
43. Taggart AJ, McDermott B, Delargy M, Elborn S, Forbes J, Roberts SD, Ahnfelt NO. The pharmacokinetics of sulphasalazine in young and elderly patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology 1987; (suppl) 64: 29-36.
44. Kean WF, Bellamy N, Brooks PM. Gold therapy in the elderly rheumatoid arthritis patient. Arthritis & Rheumatism 1983; 26: 705-11.
45. Bressolle F, Bologna C, Kinowski JM, Arcos B, Sany J, Combe B. Total and free methotrexate pharmacokinetics in elderly patients with rheumatoid arthritis. A comparison with young patients. Journal of Rheumatology 1997; 24: 1903-9.
46. Tett SE, Triggs EJ. Use of methotrexate in older patients. A risk-benefit assessment. Drugs & Aging 1996; 9: 458-71.
47. Sibilia J, Friess S, Schaeverbeke T, Maloisel F, Bertin P, Goichot B, Kuntz JL. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE): a form of paraneoplastic polyarthritis? Journal of Rheumatology 1999; 26: 115-20.
48. Isturiz Abadia A, Bartolome Resano R, Olcoz Flamarique FJ, del Cazo Cativiela J. Benign edematous benign (RS3PE) in a an elderly person. Revista Clinica Espanola 1998; 198: 712.
49. Tada Y, Sato H, Yoshizawa S, Kimura H, Kitamura M, Kusaba T, Nagasawa, K. Remitting seronegative symmetrical synovitis with pitting edema associated with gastric carcinoma. Journal of Rheumatology 1997; 24: 974-5.
50. Caplanne D, Tubach F, Le Parc JM. Late onset spondylarthropathy: clinical and biological comparison with early onset patients. Annals of the Rheumatic Diseases 1997; 56: 176-9.
51. Schreckenberg C, Asch PH, Sibilia J, Walter S, Lipsker D, Heid E, Grosshans E. Interstitial granulomatous dermatitis and paraneoplastic rheumatoid polyarthritis disclosing cancer of the lung. Ann Dermatol Venereol 1998; 125: 585-8.
52. Pines A, Kaplinsky N, Olchovsky D, Frankl O. Rheumatoid arthritis-like syndrome: a presenting symptom of malignancy. Report of 3 cases and review of the literature. Eur J Rheumatol Inflamm 1984; 7: 51-5.
53. Zvaifler N. Cancer and other miscellaneous arthropathies. In: Klippel JH, Dieppe PA (eds). Rheumatology. London: Mosby 1998: 28.1-28.6.
54. Rozenberg S, Koeger AC, Bourgeois P. Annales de Radiologie 1992; 35: 396-401.
55. Bridges AJ, Hickman PL. RS3PE syndrome and polymyalgia rheumatica: distinguishing features. Journal of Rheumatology 1991; 18: 1764-5.
56. Dieppe PA, Doherty M, Macfarlane DG, Hutton CW, Bradfield JW, Watt I. Apatite associated destructive arthritis. British Journal of Rheumatology 1984; 23: 84-91.
57. S.DeSeze, A.Babault, S.Random. L'epaule senile hemorrhagique. L'Actualité Rheumatologique. Paris: Expansion Scientifique Française 1968: 107-15.
58. Hazleman BL. Polymyalgia rheumatica and giant cell arteritis. In: Klippel JH, Dieppe PA (eds). Rheumatology. London: Mosby 1998: 7.21.1-7.21.8.
59. Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. British Journal of Rheumatology 1996; 35: 1161-8.
60. Bahlas S, Ramos-Remus C, Davis P. Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis. Journal of Rheumatology 1998; 25: 99-104.
61. Hunder GG. Clinical features of GCA/PMR. Clinical & Experimental Rheumatology 2000; 18: S6-8.
62. Boiardi L, Salvarani C, Macchioni P, Casadei MM, Mancini R, Beltrandi E, Portioli I. CD8 lymphocyte subsets in active polymyalgia rheumatica: comparison with elderly-onset and adult rheumatoid arthritis and influence of prednisone therapy. British Journal of Rheumatology 1996; 35: 642-8.
63. Meliconi R, Pulsatelli L, Uguccioni M, Salvarani C, Macchioni P, Melchiorri C, Focherini MC, Frizziero L, Facchini A. Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment. Arthritis & Rheumatism 1996; 39: 1199-207.
64. Cantini F, Salvarani C, Olivieri I, Niccoli L, Macchioni P, Boiardi L, Mastrorosato M, Ciancio G, Padula A, Bozza A, Rubini F. Inflamed shoulder structures in polymyalgia rheumatica with normal erythrocyte sedimentation rate. Arthritis & Rheumatism 2001; 44: 1155-9.
65. Pavlica P, Barozzi L, Salvarani C, Cantini F, Olivieri, I. Magnetic resonance imaging in the diagnosis of PMR. Clinical & Experimental Rheumatology 2000; 18: S38-9.
66. Gonzalez-Gay MA, Garcia-Porrua C, Salvarani C, Olivieri, I, Hunder GG. Polymyalgia manifestations in different conditions mimicking polymyalgia rheumatica. Clinical & Experimental Rheumatology 2000; 18: 755-9.
67. Glennas A, Kvien TK, Andrup O, Karstensen B, Munthe E. Recent onset arthritis in the elderly: a 5 year longitudinal observational study. Journal of Rheumatology 2000; 27: 101-8.
68. Dimant J. Rheumatoid arthritis in the elderly, presenting as polymyalgia rheumatica. Journal of the American Geriatrics Society 1979; 27: 183-5.
69. Wilke WS, Sheeler LR, Makarowski WS. Hypothyroidism with presenting symptoms of fibrositis. Journal of Rheumatology 1981; 8: 626-31.
70. Pullman-Mooar S, Gordon GV. Is there seasonal variation in the onset of symptoms for polymyalgia rheumatica and giant cell arteritis? A community based study. ACR 64th Meeting Poster [202] 2000.
71. Faerk KK. Simultaneous occurrence of polymyalgia rheumatica in a married couple. Journal of Internal Medicine 1992; 231: 621-2.
72. Kyle MV, Hazleman BL, King RH. Polymyalgia rheumatica/giant cell arteritis in husband and wife. Clinical Rheumatology 1984; 3: 395-6.
73. Uddhammar A, Boman J, Juto P, Rantapaa Dahlqvist S. Antibodies against Chlamydia pneumoniae, cytomegalovirus, enteroviruses and respiratory syncytial virus in patients with polymyalgia rheumatica. Clinical & Experimental Rheumatology 1997; 15: 299-302.
74. Dasgupta B, Panayi GS. Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis. British Journal of Rheumatology 1990; 29: 456-8.
75. Straub RH, Gluck T, Cutolo M, Georgi J, Helmke K, Scholmerich J, Vaith P, Lang B. The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica. Rheumatology (Oxford) 2000; 39: 624-31.
76. McCarty DJ, O'Duffy JD, Pearson L, Hunter JB. Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. JAMA 1985; 254: 2763-7.
77. Chaouat D, Perier JY, Le Parc JM, Belange G. Subacute edematous polyarthritis in the elderly. 9 cases. Presse Médicale 1990; 19: 1705-8.
78. Finnell JA, Cuesta IA. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome: a review of the literature and a report of three case. Journal of Foot & Ankle Surgery 2000; 39: 189-93.
79. Cantini F, Salvarani C, Olivieri I, Barozzi L, Macchioni L, Niccoli L, Padula A, Pavlica P, Boiardi L. Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study. Annals of the Rheumatic Diseases 1999; 58: 230-6.
80. Cobeta Garcia JC, Martinez Burgui J. RS3PE syndrome or benign edematous polysynovitis in the elderly. Study of 8 cases. Revista Clinica Espanola 1999; 199: 785-9.
81. Olive A, del Blanco J, Pons M, Vaquero M, Tena X. The clinical spectrum of remitting seronegative symmetrical synovitis with pitting edema. The Catalan Group for the Study of RS3PE. Journal of Rheumatology 1997; 24: 333-6.
82. Ethiopia A, Bell D. Gastric carcinoma in association with remitting seronegative symmetrical synovitis with pitting edema. Journal of Rheumatology 1999; 26: 1203-4.
83. Berthier S, Toussirot E, Wendling D. Acute benign edematous polyarthritis in the elderly (or RA3PE syndrome). Clinical course a propos of 13 cases. Presse Médicale 1998; 27: 1718-22.
84. Vinci M, Malaguarnera L, Pistone G. RS3PE and ovarian cancer. Annals of the Rheumatic Diseases 2001; 60: 429-31.
85. Cantini F, Salvarani C, Olivieri I. Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema. Clinical & Experimental Rheumatology 1999; 17: 741-4.
86. Schaeverbeke T, Fatout E, Marce S, Vernhes JP, Halle O, Antoine JF, Lequen L, Bannwarth B, Dehais J. Remitting seronegative symmetrical synovitis with pitting oedema: disease or syndrome? Annals of the Rheumatic Diseases 1995; 54: 681-4.
87. Billey T, Navaux F, Lassoued S. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) as the first manifestation of periarteritis nodosa. Report of a case. Revue du Rhumatisme 1995; 62: 53-4.
88. KoegerAC, Karmochkine M, Chaibi P. RS3PE syndrome associated with advanced ankylosing spondylitis. Journal of Rheumatology 1995; 22: 375-6.
89. Cimmino MA, Silvestri E, Garlaschi G. Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) as recurrence of aborted PMR. Annals of the Rheumatic Diseases 2001, 60: 303.
90. Magy N, Michel F, Auge B, Toussirot E, Wendling D. Amyloid arthropathy revealed by RS3PE syndrome. Revue du Rhumatisme 2000; 67: 475-7.